Method for identifying risk cardiovascular disease patients
AssigneeBerkeley HeartLab, Inc.
InventorsDavid Shewmake, Frank Ruderman, Christopher Boggess
Life of this patent
Estimating the term…
Abstract
The invention provides a method for identifying patients with normal NCEP lipid levels who are in need of treatment for cardiovascular disease comprising measuring one or more LDL or HDL particle subclass levels and identifying abnormal LDL or HDL subclass levels. LDL III a+b and HDL 2b are preferred subclasses.
Claims14
A method for identifying patients with normal NCEP lipid levels who are in need of treatment for cardiovascular disease comprising measuring one or more LDL or HDL particle subclass levels and identifying abnormal LDL or HDL subclass levels.
A method for identifying a human subject in need of cardiovascular disease treatment comprising identifying subjects having LDL III a+b levels of about 15% or more of the LDL particles.
A method for identifying cardiovascular patients with LDL levels below the levels indicated by NCEP for initiation of therapeutic lifestyle changes or to initiate drug therapy comprising measure the portion of small LDL particles to total LDL particles in the patient's blood serum.
Dependencies are inferred from the claim text.